• Press release
6 min time reading

2025: Another year of strong delivery

  • Corporate news
  • FY 2025 sales of €27,283m up +4.5% on a like-for-like (LFL) basis, with volume/mix up +2.7%, and price up +1.8%
  • Q4 sales up +4.7% LFL, driven again by strong volume/mix, up +2.5%, and price up +2.1%
    • Sustained momentum in Europe, driven by continued progress in EDP and solid performance in Adult Medical Nutrition and Waters
    • Soft Q4 performance in North America, despite sustained momentum in High Protein and a solid Specialized Nutrition performance
    • Closing a year of exceptional performance in China, North Asia & Oceania with strong Q4 in Specialized Nutrition and EDP
  • Recurring operating margin up +44 basis points (bps) at 13.4% driven by further improvement in margin from operations while continuing to reinvest into future growth
  • Recurring EPS up +4.6% to €3.80
  • €2.8bn Free cash flow, reflecting strong operating performance
  • Proposed dividend up +4.7% to €2.25
  • Recognized global sustainability leadership: CDP ‘Triple A’ List and worldwide B Corp certification
  • 2026 guidance in line with mid-term ambition: like-for-like sales growth expected between +3% and +5%, with recurring operating income growing faster than sales

Discover the Full Press Release here